Range Impact Announces Sale of Cannabinoid Drug Development Business
October 02, 2024 16:05 ET
|
Range Impact, Inc.
CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the...
Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer
April 26, 2024 09:20 ET
|
Range Impact, Inc.
CLEVELAND, OHIO, April 26, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or “Company”), an impact investing company dedicated to acquiring, reclaiming and repurposing mine...
MALACHITE INNOVATIONS AND ITS SUBSIDIARY GRAPHIUM BIOSCIENCES RELEASE NEW INVESTOR PRESENTATIONS AND ANNOUNCE UPCOMING FUNDRAISING EFFORTS
June 01, 2023 16:15 ET
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, June 01, 2023 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS ANNOUNCES TWO GRANTED U.S. PATENTS AND NEW PCT PATENT FILING
December 28, 2021 16:05 ET
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Dec. 28, 2021 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) announces that its wholly-owned drug development subsidiary, Graphium Biosciences, Inc., has been...
Vitality Biopharma Adopts New Name – Malachite Innovations, Inc.
October 12, 2021 09:00 ET
|
Malachite Innovations, Inc.
CLEVELAND, Ohio, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. has changed its name to MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (pronounced “mal-a-kite”) following a corporate...